586 related articles for article (PubMed ID: 23973347)
1. Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants.
Madhi SA; Dangor Z; Heath PT; Schrag S; Izu A; Sobanjo-Ter Meulen A; Dull PM
Vaccine; 2013 Aug; 31 Suppl 4():D52-7. PubMed ID: 23973347
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa.
Kim SY; Russell LB; Park J; Verani JR; Madhi SA; Cutland CL; Schrag SJ; Sinha A
Vaccine; 2014 Apr; 32(17):1954-63. PubMed ID: 24530145
[TBL] [Abstract][Full Text] [Related]
3. Preventing the broad spectrum of perinatal morbidity and mortality through group B streptococcal vaccination.
Edwards MS; Gonik B
Vaccine; 2013 Aug; 31 Suppl 4():D66-71. PubMed ID: 23200934
[TBL] [Abstract][Full Text] [Related]
4. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine.
Schrag SJ; Verani JR
Vaccine; 2013 Aug; 31 Suppl 4():D20-6. PubMed ID: 23219695
[TBL] [Abstract][Full Text] [Related]
5. Prospects for preventing infant invasive GBS disease through maternal vaccination.
Madhi SA; Dangor Z
Vaccine; 2017 Aug; 35(35 Pt A):4457-4460. PubMed ID: 28237500
[TBL] [Abstract][Full Text] [Related]
6. Prevention of group B streptococcal disease in the first 3 months of life: would routine maternal immunization during pregnancy be cost-effective?
Oster G; Edelsberg J; Hennegan K; Lewin C; Narasimhan V; Slobod K; Edwards MS; Baker CJ
Vaccine; 2014 Aug; 32(37):4778-85. PubMed ID: 24992717
[TBL] [Abstract][Full Text] [Related]
7. Neonatal group B streptococcal disease: from pathogenesis to preventive strategies.
Melin P
Clin Microbiol Infect; 2011 Sep; 17(9):1294-303. PubMed ID: 21672083
[TBL] [Abstract][Full Text] [Related]
8. GBS public awareness, advocacy, and prevention--what's working, what's not and why we need a maternal GBS vaccine.
Burns G; Plumb J
Vaccine; 2013 Aug; 31 Suppl 4():D58-65. PubMed ID: 23973348
[TBL] [Abstract][Full Text] [Related]
9. Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis.
Jordan HT; Farley MM; Craig A; Mohle-Boetani J; Harrison LH; Petit S; Lynfield R; Thomas A; Zansky S; Gershman K; Albanese BA; Schaffner W; Schrag SJ;
Pediatr Infect Dis J; 2008 Dec; 27(12):1057-64. PubMed ID: 18989238
[TBL] [Abstract][Full Text] [Related]
10. Systematic review of the clinical development of group B streptococcus serotype-specific capsular polysaccharide-based vaccines.
Dzanibe S; Madhi SA
Expert Rev Vaccines; 2018 Jul; 17(7):635-651. PubMed ID: 29961350
[TBL] [Abstract][Full Text] [Related]
11. The Italian arm of the PREPARE study: an international project to evaluate and license a maternal vaccine against group B streptococcus.
Berardi A; Cassetti T; Creti R; Vocale C; Ambretti S; Sarti M; Facchinetti F; Cose S; ; Heath P; Le Doare K
Ital J Pediatr; 2020 Oct; 46(1):160. PubMed ID: 33115542
[TBL] [Abstract][Full Text] [Related]
12. Developing a serocorrelate of protection against invasive group B streptococcus disease in pregnant women: a feasibility study.
Carreras-Abad C; Cochet M; Hall T; Ramkhelawon L; Khalil A; Peregrine E; Vinayakarao L; Sivarajan S; Hamid R; Planche T; Sheridan E; Winchester S; Plumb J; Djennad A; Andrews N; Le Doare K; Heath P
Health Technol Assess; 2019 Dec; 23(67):1-40. PubMed ID: 31855555
[TBL] [Abstract][Full Text] [Related]
13. Group B streptococcal epidemiology and vaccine needs in developed countries.
Melin P; Efstratiou A
Vaccine; 2013 Aug; 31 Suppl 4():D31-42. PubMed ID: 23973345
[TBL] [Abstract][Full Text] [Related]
14. Preventing neonatal group B streptococcal infection. Intrapartum antibiotic prophylaxis in some high-risk situations.
Prescrire Int; 2011 Mar; 20(114):72-7. PubMed ID: 21648230
[TBL] [Abstract][Full Text] [Related]
15. An overview of global GBS epidemiology.
Le Doare K; Heath PT
Vaccine; 2013 Aug; 31 Suppl 4():D7-12. PubMed ID: 23973349
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial.
Madhi SA; Cutland CL; Jose L; Koen A; Govender N; Wittke F; Olugbosi M; Meulen AS; Baker S; Dull PM; Narasimhan V; Slobod K
Lancet Infect Dis; 2016 Aug; 16(8):923-34. PubMed ID: 27139805
[TBL] [Abstract][Full Text] [Related]
17. Early-onset group B streptococcal disease in the era of maternal screening.
Puopolo KM; Madoff LC; Eichenwald EC
Pediatrics; 2005 May; 115(5):1240-6. PubMed ID: 15867030
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of a potential group B streptococcal vaccine for pregnant women in the United States.
Kim SY; Nguyen C; Russell LB; Tomczyk S; Abdul-Hakeem F; Schrag SJ; Verani JR; Sinha A
Vaccine; 2017 Oct; 35(45):6238-6247. PubMed ID: 28951085
[TBL] [Abstract][Full Text] [Related]
19. Early-onset group B streptococcal disease in African countries and maternal vaccination strategies.
Dangor Z; Seale AC; Baba V; Kwatra G
Front Public Health; 2023; 11():1214844. PubMed ID: 37457277
[TBL] [Abstract][Full Text] [Related]
20. [Prevention of perinatal infection caused by group B beta-hemolytic streptococcus].
Bevilacqua G
Acta Biomed Ateneo Parmense; 1999; 70(5-6):87-94. PubMed ID: 11402819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
